Clinical Trials Browser

Completed × Interventional × Advanced Triple-Negative Breast Cancer × Clear all

NCT03254654 2022-04-20

Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer

Phase 2 Completed

Advanced Triple-Negative Breast Cancer